Abacus Life (ABL) said late Thursday it priced an underwritten public offering of 12.5 million common shares at $8 apiece.
The company is offering 10 million shares, with the rest to be sold by certain stockholders. It also granted underwriters a 30-day option to purchase up to an additional 1.5 million shares from the company and up to 375,000 more shares from the selling stockholders.
The offering is expected to close on Nov. 25.
Abacus said gross proceeds are expected to be about $100 million, excluding the underwriters' option to purchase additional shares.
The company plans to use the proceeds for its operations, including the purchase of life settlement policies, among other things.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。